SOMNF (SomnoMed) Tax Provision: $-1.58 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SOMNF SomnoMed Ltd SOMNF
49 GF Score
Price $0.45
GF Value $0.41
! 3 Warning Signs
View Full Analysis

What is SomnoMed Tax Provision?

SomnoMed SOMNF 49 Tax Provision is $-1.58 Mil as of Dec. 2025. GuruFocus rates SOMNF with a GF Score™ of 49/100 and a GF Value™ of $0.41. The stock has 3 warning signs investors should review.

SomnoMed's tax provision for the six months ended in Dec. 2025 was $-0.87 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.58 Mil.

SomnoMed Tax Provision Historical Data

* Premium members only.

The historical data trend for SomnoMed's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Tax Provision Chart

SomnoMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.65 -0.55 -0.65 -1.75

SomnoMed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.54 -0.11 -1.02 -0.70 -0.87
SOMNF
49GF Score
SomnoMed Ltd SOMNF
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of $-1.58 Mil mean?
SomnoMed (SOMNF) has a Tax Provision of $-1.58 Mil as of Dec. 2025. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on SomnoMed and its competitors.
Is SomnoMed's Tax Provision too high?
SomnoMed's current Tax Provision is $-1.58 Mil. Overall, SomnoMed has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Tax Provision compare to ABT and SYK?
SomnoMed's Tax Provision of $-1.58 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Medical Devices & Instruments company?
A good Tax Provision depends on the Medical Devices & Instruments industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on SomnoMed and its competitors. SomnoMed's current Tax Provision is $-1.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
SomnoMed (SOMNF) has a current Tax Provision of $-1.58 Mil. The stock's GF Value™ is $0.41, compared to a current price of $0.45 — trading 9.2% above its estimated fair value. The current Tax Provision is $-1.58 Mil. SomnoMed's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For SomnoMed (SOMNF), the current Tax Provision is $-1.58 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (SOMNF) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of $0.45 is trading 9.2% above its estimated GF Value™ of $0.41.

Key valuation signals for SOMNF:

  • Tax Provision: $-1.58 Mil
  • GF Value™: $0.41 vs. price of $0.45 (9.2% above fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges RJV:GermanySOM:Australia
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
49GF Score

Get the complete analysis for SOMNF

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.45
Price
$0.41
GF Value